This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Dec 6;384(9959):2004-6.

doi: 10.1016/S0140-6736(14)61008-4. Epub 2014 Aug 6.

Prostate cancer screening comes of age

Ian M Thompson¹, Catherine M Tangen²

Affiliations

Affiliations

¹ Cancer Therapy and Research Center, University of Texas HSC at San Antonio, San Antonio, TX 78229, USA. Electronic address: thompsoni@uthscsa.edu.
² Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

PMID: 25108887
DOI: 10.1016/S0140-6736(14)61008-4

Comment

Prostate cancer screening comes of age

Ian M Thompson et al. Lancet. 2014.

. 2014 Dec 6;384(9959):2004-6.

doi: 10.1016/S0140-6736(14)61008-4. Epub 2014 Aug 6.

Authors

Ian M Thompson¹, Catherine M Tangen²

Affiliations

¹ Cancer Therapy and Research Center, University of Texas HSC at San Antonio, San Antonio, TX 78229, USA. Electronic address: thompsoni@uthscsa.edu.
² Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

PMID: 25108887
DOI: 10.1016/S0140-6736(14)61008-4

No abstract available

PubMed Disclaimer

Comment on

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Määttänen L, Lilja H, Denis LJ, Recker F, Paez A, Bangma CH, Carlsson S, Puliti D, Villers A, Rebillard X, Hakama M, Stenman UH, Kujala P, Taari K, Aus G, Huber A, van der Kwast TH, van Schaik RH, de Koning HJ, Moss SM, Auvinen A; ERSPC Investigators. Schröder FH, et al. Lancet. 2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6. Lancet. 2014. PMID: 25108889 Free PMC article. Clinical Trial.

Similar articles

Re: Screening and Prostate Cancer Mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 Years of Follow-up.
Taneja SS. Taneja SS. J Urol. 2015 Aug;194(2):392. doi: 10.1016/j.juro.2015.05.064. Epub 2015 May 18. J Urol. 2015. PMID: 26195362 No abstract available.
Words of wisdom. Re: Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Bill-Axelson A, Bratt O. Bill-Axelson A, et al. Eur Urol. 2015 Jan;67(1):175. doi: 10.1016/j.eururo.2014.09.048. Epub 2014 Nov 25. Eur Urol. 2015. PMID: 25528396 No abstract available.
[Screening for prostatic cancer].
Pushkar' DIu, Govorov AV, Bormotin AV. Pushkar' DIu, et al. Urologiia. 2003 Jan-Feb;(1):10-5. Urologiia. 2003. PMID: 12621959 Russian.
The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: the prostate cancer screening results in context.
Berg CD. Berg CD. Acta Oncol. 2011 Jun;50 Suppl 1:12-7. doi: 10.3109/0284186X.2010.531283. Acta Oncol. 2011. PMID: 21604935 Review.
Prostate cancer screening: more harm than good?
Lefevre ML. Lefevre ML. Am Fam Physician. 1998 Aug;58(2):432-8. Am Fam Physician. 1998. PMID: 9713397 Review.

See all similar articles

Cited by

Exploring the impact of PEGylation on pharmacokinetics: a size-dependent effect of polyethylene glycol on prostate-specific membrane antigen inhibitors.
Liu Y, Xia L, Li H, Cai P, Tang S, Feng Y, Liu G, Chen Y, Liu N, Zhang W, Zhou Z. Liu Y, et al. EJNMMI Res. 2024 Feb 7;14(1):15. doi: 10.1186/s13550-024-01071-z. EJNMMI Res. 2024. PMID: 38324095 Free PMC article.
Polypeptide-Based Molecular Platform and Its Docetaxel/Sulfo-Cy5-Containing Conjugate for Targeted Delivery to Prostate Specific Membrane Antigen.
Petrov SA, Machulkin AE, Uspenskaya AA, Zyk NY, Nimenko EA, Garanina AS, Petrov RA, Polshakov VI, Grishin YK, Roznyatovsky VA, Zyk NV, Majouga AG, Beloglazkina EK. Petrov SA, et al. Molecules. 2020 Dec 8;25(24):5784. doi: 10.3390/molecules25245784. Molecules. 2020. PMID: 33302417 Free PMC article.
LINC00689 promotes prostate cancer progression via regulating miR-496/CTNNB1 to activate Wnt pathway.
Meng L, Li Z, Chen Y, Liu D, Liu Z. Meng L, et al. Cancer Cell Int. 2020 Jun 5;20:215. doi: 10.1186/s12935-020-01280-1. eCollection 2020. Cancer Cell Int. 2020. PMID: 32518524 Free PMC article.
Cancer prevention as part of precision medicine: 'plenty to be done'.
Stewart BW, Bray F, Forman D, Ohgaki H, Straif K, Ullrich A, Wild CP. Stewart BW, et al. Carcinogenesis. 2016 Jan;37(1):2-9. doi: 10.1093/carcin/bgv166. Epub 2015 Nov 20. Carcinogenesis. 2016. PMID: 26590901 Free PMC article. Review.
MicroRNA-143 acts as a tumor suppressor by targeting hexokinase 2 in human prostate cancer.
Zhou P, Chen WG, Li XW. Zhou P, et al. Am J Cancer Res. 2015 May 15;5(6):2056-63. eCollection 2015. Am J Cancer Res. 2015. PMID: 26269764 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information